ICL Surgeon Dr. Paul Dougherty on Visian ICL
Vista Vision ICL Procedure
Dougherty Laser Vision was the first vision correction center in the Western U.S. to offer the remarkable STAAR Visian ICL (Implantable Contact Lens) for the treatment of mild to severe nearsightedness and the first surgeon in the U.S. to perform the Visian ICL procedure on both of a patient’s eyes during the same office visit.
As one of the leading implanters in the United States, Dr. Dougherty developed his own implantation technique know as the Vista Vision ICL Procedure.
The Vista Vision ICL Procedure benefits patients by reducing the surgery from four separate surgical procedures into a single surgical session, and speeds up the visual recovery time so that the patient experience with Visian ICL implantation is just like LASIK. In fact, in our practice, we refer to the Visian ICL procedure as “LASIK with a lens”. Like LASIK, most patients have significantly improved vision the day after surgery with minimal discomfort and most patients are back to work or school within 48 hours.
Dougherty Laser Vision is one of the first Visian ICL centers in the nation to offer the Sonomed UBM (ultrasound bio-microscopy), which measures the precise area for lens insertion to improve sizing of the lens. This technology helps Dr. Dougherty perform the implant procedure with exceptional precision.
What is the Visian ICL?
Approved by the FDA in December 2005, the Visian ICL is an implantable contact lens made of a biocompatible material called Collamer that allows the lens to be rolled into a tiny cylinder for insertion into the eye. As the lens is inserted, it gently unfolds behind the iris, where it remains virtually undetectable to an observer. The ICL is self-cleaning and needs no maintenance, unlike traditional contact lenses.
The Visian ICL can provide clear vision for nearsighted patients who demand a higher quality of vision than LASIK or who do not want a flap. Visian ICL is also an excellent option for patients who are not good candidates for LASIK due to thin or irregular corneas, dry eyes, or prescriptions that exceed the acceptable range for LASIK.
Dr. Dougherty helped pioneer the Visian ICL technology and was one of just a handful of surgeons in the U.S. to serve as a principal investigator for the Visian ICL FDA clinical study. As such, he has implanted the Visian ICL internationally and on an investigational basis since 1999, long before it was approved for use in the US. In December 2005, Dougherty Laser Vision hosted the first post-approval ICL training session for U.S. surgeons, and ophthalmologists from across the nation continue to come to our surgery centers to observe Dr. Dougherty performing the ICL procedure.
Visian Toric ICL
Receiving FDA approval in 2018, the Visian Toric ICL is a variant of the existing Visian ICL technology. The Toric ICL has the same unique design as the original and can be implanted using the same personally developed technique created by Dr. Dougherty. The Toric ICL is an appealing new treatment option for patients affected by moderate to high myopia and astigmatism.
The Toric ICL, like it’s predecessor, is a long-term vision correction solution that requires no maintenance, is self-cleaning, and is virtually undetectable. Dr. Dougherty has been implanting these lenses internationally for years and is the first surgeon on the West Coast to implant the Toric ICL.
“FDA’s approval of STAAR’s Visian Toric ICL provides an exciting treatment option for myopic patients with astigmatism in search of visual freedom. We are pleased to partner with Paul Dougherty of Dougherty Laser Vision, who will be the first on the West Coast to offer this technology to his patients,” said Jim Francese, Sr. Vice President Commercial Operations of STAAR Surgical.